NeoGenomics, Inc. Other Non-Current Liabilities
NeoGenomics, Inc. (NEO) had Other Non-Current Liabilities of $862.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-07-28
- 2026-06-30: Other Liabilities, Noncurrent $862.00K.
- 2026-03-31: Other Liabilities, Noncurrent $12.03M.
- 2025-12-31: Other Liabilities, Noncurrent $12.04M; Other Liabilities, Noncurrent as first filed $12.07M.
- 2025-09-30: Other Liabilities, Noncurrent $11.98M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $862.00K 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $12.03M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $12.04M 10-Q · filed 2026-07-28 | $12.07M 10-K · filed 2026-02-17 |
| 2025-09-30 | $11.98M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $12.10M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $11.92M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $11.77M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $11.60M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $11.55M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $13.03M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $13.03M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $13.04M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $13.03M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $13.04M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $13.05M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $14.17M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $14.16M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $14.14M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $14.02M 10-K · filed 2023-02-24 | $13.95M 10-K · filed 2022-02-25 |
| 2021-09-30 | $14.43M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.80M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $3.71M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $4.06M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $3.94M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $3.15M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $4.24M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $3.57M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $4.67M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $4.44M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $3.74M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $3.06M 10-K · filed 2020-02-28 | |
| 2017-12-31 | $283.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |